The largest database of trusted experimental protocols

7 protocols using ceftazidime

1

Antimicrobial Resistance Profiling of P. mirabilis

Check if the same lab product or an alternative is used in the 5 most similar protocols
P. mirabilis isolates were tested for their resistance to different antimicrobials using the disk diffusion method [32 ]. The antimicrobials used were amoxicillin-clavulanic acid (AMC; 30 mg), imipenem (IMP; 10 mg), cefoxitin (FOX; 30 mg), ceftazidime (CAZ; 30 mg), ciprofloxacin (CIP; 5 mg), cefotaxime; (CTX; 30 mg), and amikacin (AK; 30 mg) (Bioanalyse, Ankara, Turkey).
+ Open protocol
+ Expand
2

Antimicrobial Susceptibility Testing of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility of the isolates to 17 antimicrobial agents was determined on Mueller–Hinton agar (Oxoid, UK) using the Kirby Bauer disc diffusion method, according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2020). The tested antimicrobial agents (Bioanalyse, Turkey) included Amoxicillin/clavulanate (30 µg), cefepime (30 µg), cefotaxime (30 µg), cefoxitin (30 µg), ceftriaxone (30 µg), ceftazidime (30 µg), aztreonam (10 µg), imipenem (10µg), amikacin (30 µg), gentamicin (10 µg), ciprofloxacin (5 µg), tetracycline (30 µg), trimethoprim 1.25 µg/sulphamethoxazole 23.75 µg (SXT, 25 µg), chloramphenicol (30 µg), nitrofurantoin (300 µg), and tigecycline (15 µg). The broth microdilution assay was used to determine the minimum inhibitory concentrations (MICs) of colistin. The breakpoints proposed by the European Committee on Antimicrobial Susceptibility Testing [34 ] were used for interpreting the antimicrobial susceptibility tests of tigecycline and colistin. MDR and XDR phenotypes were inferred according to the definitions of Magiorakos et al. [35 (link)].
+ Open protocol
+ Expand
3

UPEC Antibiotic Resistance Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Altogether n = 155 identified uropathogenic E. coli (UPEC) were collected during the period of August 2012 to August 2014, from Pakistan Institute of Medical Sciences. Ethical Review Board (ERB) of Pakistan Institute of Medical Sciences approved this study. Ethical Review Board approved verbal consent taken from all the patients. Important patient data such as name, age, gender, location was recorded and unique identification number were assigned to each patient. Samples were from community-acquired urinary tract infections. Antibiotic testing and phenotypic detections of ESBL were performed by disc diffusion methods according to the guidelines CLSI, 2014 [13 ]. Isolates were tested for the susceptibility to 12 different classes of antibiotics including β-lactamase inhibitors (piperacillin tazobactam, amoxicillin-clavulanic acid), cephalosporins (ceftazidime, cefotaxime, ceftriaxone), fluoroquinolone (ciprofloxacin, levofloxacin), aminoglycosides (amikacin), trimethoprim sulfonamides, nitrofurantoin, and fosfomycin (BIOANALYSE, Turkey). Control strain E. coli ATCC 25922 was used in this assay.
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing of ESBL-Producing K. pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ESBL-producing K. pneumoniae isolates were tested for
antimicrobial susceptibility testing (AST) using disk diffusion technique
according to the Clinical and Laboratory Standards Institute (CLSI)
instructions9. Antimicrobials were classified as follows: aztreonam (ATM, 30 μg),
gentamicin (CN, 10 μg), ciprofloxacin (CIP, 5 μg), ceftazidime (CAZ, 30 μg),
levofloxacin (LEV, 5 μg), amoxicillin/clavulanate (AMC, 30 μg), trimethoprim
(TMP, 5 μg), norfloxacin (NOR, 10 μg), cefotaxime (CTX, 30 μg), nitrofurantoin
(F, 300 μg), imipenem (IPM, 10 μg), chloramphenicol (C, 30 μg), tetracycline
(TE, 30 μg), and ceftriaxone (CRO, 30 μg) (Bioanalyse, Turkey). MDR isolates
were determined according to the previous definition (resistance to at least one
member of three antibiotics classes)10. Escherichia coli ATCC 25922 and K.
pneumonia
e ATCC 700603 were used as quality control strains.
+ Open protocol
+ Expand
5

Antimicrobial Susceptibility Testing: Disk Diffusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility of the isolates was performed by the disk diffusion method according to the instructions of CLSI [30 ] using Mueller-Hinton agar (HIMEDIA, India). The used antimicrobials were obtained from Bioanalyse/ Turkey and included: ampicillin (AMP: 10 μg); amoxicillin-clavulanic acid (AMC: 20/10 μg); cefoxitin (FOX: 30 μg); cefotaxime (CTX: 30 μg); ceftazidime (CAZ: 30 μg); ceftriaxone (CRO: 30 μg); cefepime (FEP: 30 μg); aztreonam (ATM: 30 μg); imipenem (IPM: 10 μg); meropenem (MEM: 10 μg); gentamicin (CN: 10 μg); amikacin (AK: 30 μg); tetracycline (TE: 30 μg); nalidixic acid (NA: 30 μg); ciprofloxacin (CIP: 5 μg); trimethoprim-sulfamethoxazole (SXT: 1.25/23.75 μg); and nitrofurantoin (F: 300 μg).
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Susceptibility testing was performed using the Kirby-Bauer disk diffusion method on Mueller Hinton agar. 6 different types of antibiotics were used, including ceftriaxone (CRO30𝜇g), ceftazidime (CAZ30𝜇m), cefotaxime (CTX30𝜇m), amoxycilin/clavulanic acid 2/1 (AMC), meropenem (Mem10𝜇m), and amoxicillin (AX25𝜇m) (Bioanalyse, Ankara, Turkey).
+ Open protocol
+ Expand
7

ESBL Detection in Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial suspensions were adjusted to 0.5 McFarland turbidity and spread evenly in all directions on MHA . Ceftazidime (30 µg) and Ceftazidime/clavulanic acid (30/10 µg) disks (Bioanalyse, Turkey) were placed onto the MHA and the plates were incubated for 16-18 hours at 37 °C (8) . An increase in the zone diameter of ≥ 5 mm for either antimicrobial agent tested in combination with clavulanic acid over that when tested alone was confirmed as ESBL positive strains according to the Clinical and Laboratory Standards Institute (CLSI) criteria (8) . Klebsiella pneumoniae (K pneumoniae) ATCC 700603 and Escherichia coli (E coli) ATCC 25922 were used as ESBL positive and negative control strains.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!